Reaction
Complement Factor Abnormal reporting signals
As of the last recalculation, Complement Factor Abnormal appears in 105 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is ECULIZUMAB (PRR 360.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eculizumab | 51 | 360.8 | 361.2 |
| Ravulizumab | 4 | 61.0 | 61.0 |